Society for Research on Nicotine and Tobacco
The Society for Research on Nicotine and Tobacco (SRNT) holds an annual conference focusing across disciplines in the field of nicotine and tobacco research, with topics ranging from clinical studies to tobacco regulation. The event is aimed at academics, researchers, policymakers, and other professionals involved with nicotine and tobacco products, and provides a forum for sharing knowledge and collaborating to identify future trends across the full spectrum of basic and applied research on nicotine and tobacco.
SRNT 2021
Date
Feb 24, 2021 - Feb 27, 2021
Location
Online
This year's meeting is held in a completely virtual environment. The theme for the SRNT virtual meeting is focused on the timely and enduring issues of social justice, health inequality, and importantly, action to correct health disparities of nicotine and tobacco. At this event, PMI scientists present the following posters and presentations including on the characterization of the aerosol generated by a heated tobacco product.
See related presentations
- IQOS Use Prevalence and History of Tobacco Product Use: Findings from Surveys in Japan, Italy, and Germany
- Qualitative Health and Functioning Concept Elicitation Interviews in Japanese Users of Heated Tobacco Products
- Scientific Substantiation of the Absence of Combustion in a Novel Heated Tobacco Product
- Development of a 3D Intestinal Model for Assessing the Immunomodulatory Properties of Anti-inflammatory Compounds
- Influence of the Introduction of Heated Tobacco Products on IHD and COPD Hospitalizations in Japan using Real-World Data
- Assessing the Effects of Switching from Cigarettes to the Tobacco Heating System Relative to Smoking Cessation on Biomarkers of Potential Harm – Additional Evidence on the Potential to Reduce the Risk of Smoking-related Diseases
- Comprehensive Chemical Characterization of the Aerosol Generated by Heated Tobacco Product
- Toxicological Assessment of Flavored e-liquids in Sprague Dawley Rats in an OECD Subchronic Inhalation Study Complemented by Systems Toxicology Endpoints
SRNT 2019
Date
Feb 20, 2019 - Feb 23, 2019
Location
San Francisco, USA
The 25th Annual Meeting program theme focuses on tobacco-related health disparities and underserved populations.
See related posters
- Systems Toxicology Assessment of a 72-Hour Repeated Exposure to Swedish Snus Extract and Total Particulate Matter from 3R4F Cigarette Smoke on Gingival Organotypic Cultures
- A Multicenter, Multiregional Study on Biological and Functional Changes in Healthy Adult Smokers During One Year of Continuous Smoking Abstinence
- Biomarker discovery for nicotine-containing product assessment can be facilitated by INTERVALS, a platform to share and analyze non-clinical and clinical data
- Decreased Levels of Biomarkers of Exposure in Smokers Switching to Carbon-Heated Tobacco Product 1.2 compared with those who continued to smoke: A Randomized, Controlled, Open-Label 90-Day Exposure Study
- Cardiovascular Effects Observed When Using the Tobacco Heating System (THS) Compared with Continued Smoking
- Differences in Perceived Health Risk of Cigarettes and IQOS® by Current Product Use Categories and Intention to Quit: A Cross-Sectional Study in Japan
- Creating a Repository for the Assessment of Tobacco-Related Behavioral Outcomes: A Case Example
- Test-Retest Reliability of the Lifestyle Questionnaire: Post-hoc Analysis of a Smoking Cessation Study
- Exploring Discriminant Capacity of Urinary CEMA as Combustion Marker in Tobacco Users - A Population Pharmacokinetic Approach
- Impact of Switching to a Heat-Not-Burn Tobacco Product on CYP1A2 Activity: A Review of Four Clinical Studies
- Interfacial Dynamics of the Model Pulmonary Surfactant in the Presence of Glycerol/Propylene Glycol Mixtures
- Nicotine Pharmacokinetics and Subjective Effects Following Use of a Novel Nicotine-Containing Powder Product
- Nicotine Pharmacokinetics and Pharmacodynamic Effects of P4M3 Compared with Subjects’ Own Electronic Cigarette
- Sociodemographic Characteristics of “Heat-not-Burn” Product Users Compared with Cigarette Smokers: First-Year Results of a Repeated Cross-Sectional Survey in Japan
- Psychometric Validation of the ABOUT–Dependence : A Fit-for-Purpose Instrument to Assess Global Dependence on Tobacco and Nicotine Products
SRNT 2018
Date
Feb 21, 2018 - Feb 24, 2018
Location
Baltimore, USA
This year the program has an emphasis on understanding and treating tobacco use among populations experiencing disproportionately high burden and health consequences from tobacco use.
See related posters
- A multi-center, multi-regional study on biological and functional changes in healthy adult smokers during one year of continuous smoking abstinence
- Comparative effect of a candidate modified risk tobacco product aerosol and cigarette smoke on color stability of enamel, dentin and dental composite resins
- Development of a tobacco and nicotine products dependence instrument
- Methodology for monitoring adverse event reports for potential modified risk tobacco products: Experience at Philip Morris International
- Linguistic validation of the Perceived Risk Instrument (PRI) into French, German, Italian, Japanese, Polish and Russian
- Prediction of disease-specific death rates by using forecasts of their key predictive ecological indicators
- Psychometric evaluation of the mCEQ applied to cigarettes and heat-not-burn products in the US and Japan
- Potential Predictors of Intended Use of a Novel Heat-not-burn Tobacco Product
SRNT 2017
Date
Mar 08, 2017 - Mar 11, 2017
Location
Florence, Italy
This year there is a strong focus on concurrent use of tobacco with other psychoactive substances and drugs: findings from basic science, preclinical and clinical studies.
See related posters
- Actual use study of the Candidate Modified Risk Tobacco Product (MRTP): Tobacco Heating System (THS)
- Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Aerosol System
- Biomarker of Exposure Reductions Upon Switching for 5 Days from Cigarettes to a Carbon Heated Tobacco Product (CHTP 1.0)
- Modeling the impact of changes in tobacco use on individual disease risks
- Intention to use the Tobacco Heating System, associated with variants of a potential product brochure
- Nicotine Population Pharmacokinetics in Healthy Adult Smokers
SRNT 2016
Date
Mar 02, 2016 - Mar 05, 2016
Location
Chicago, USA
This year there scientific program includes presentations on a number of pivotal clinical trials, genomics, biomarkers, cue reactivity, marijuana and tobacco use, e-cigarettes, cigar use, waterpipes, smokeless tobacco, tobacco regulation, and modeling.
See related posters
- Establishing a Valid Model to Estimate the Impact of Introducing a Reduced Risk Product on the Population as a Whole
- High Content Screening Assessment of Nicotine Toxicity in Primary Human Bronchial Epithelial Cells
- Final Psychometric Evaluation and Cultural Adaptation of the Perceived Risk Instrument (PRI) to Measure Perceived Risks Associated with the Use of Tobacco and Nicotine-Containing Products
- Indoor Air Chemistry - An exploratory study on e-cigarette shows no negative impact on indoor air quality
- How Do Consumers Use the Candidate MRTP Tobacco Heating System (THS): Analysis of Whole Offer Test Data from Five Countries
- Study to Quantitatively Assess Tobacco Heating System 2.2 Potential Messages
- Population health impact model of introducing a reduced risk product: Initial estimate of the effective dose factor
SRNT 2015
Date
Feb 25, 2015 - Feb 28, 2015
Location
Philadelphia, USA
Researchers present more than 300 pages of tobacco-related results at 23 symposia, 25 paper sessions, and four poster sessions.
See related posters
- The Perceived Risk Instrument (PRI) To Measure Perceived Risks Associated With The Use Of Nicotine And Tobacco Products
- Toxicity of inhaled Nicotine And Pyruvic Acid Aerosols (separately and combined) in Sprague-Dawley Rats in a 28-Day OECD 412 Inhalation Study
- The Impact Of Switching To pMRTP On The Development Of Cigarette Smoke - Induced COPD In C57BL/6 Mice
- Systems Toxicology Analysis Of Cardiovascular And Respiratory Endpoints From ApoE-/- Mice Showed Similar Effects After Switching To A Candidate Modified Risk Tobacco Product, THS 2.2, Or To Smoking Cessation
- Indoor Air Chemistry (IAC) - Comparative Study Between Conventional Cigarette And Heat-Not-Burn Technology
- Human Organotypic Nasal Epithelial Tissue Culture As An In Vitro Model To Evaluate Effects Of Cigarette Smoke Of A Candidate Modified Risk Tobacco Product: The Tobacco Heating System 2.2
- Molecular markers of early stage COPD in serum, sputum, and nasal epithelium from a case-control study
- Investigation on puffing topography parameters and product evaluation recorded during five days of use of the Tobacco Heating System 2.2: A comparison with continued combustible cigarette use
- Modeling transport and evolution of aerosols for accurate predictions of local deposition in an in-vitro exposure system
- Pharmacokinetics Of Nicotine And Subjective Effects Following The Single Use Of A Non-Menthol And Menthol Version Of Tobacco Heating System 2.2 In Two Studies In Japan: A Comparison With Single Use Of A Combustible Cigarette And Nicotine Gum
- Pharmacokinetics Of Nicotine And Subjective Effects Following The Single Use Of A Menthol Version Of Tobacco Heating System 2.2 In The US: A Comparison With Single Use Of A Combustible Cigarette And Nicotine Nasal Spray
- Population health impact model to estimate the effect of introducing modified risk tobacco products on mortality
SRNT Europe 2014
Date
Sep 18, 2014 - Sep 20, 2014
Location
Santiago de Compostella, Spain
SRNT Europe 2010
Date
Sep 06, 2010 - Sep 09, 2010
Location
Bath, U.K.
See related posters
SRNT Europe 2004
Date
Oct 06, 2004 - Oct 09, 2004
Location
Tübingen, Germany